BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 31383568)

  • 1. New insights in cryoglobulinemic vasculitis.
    Silva F; Pinto C; Barbosa A; Borges T; Dias C; Almeida J
    J Autoimmun; 2019 Dec; 105():102313. PubMed ID: 31383568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryoglobulinemia (review).
    Takada S; Shimizu T; Hadano Y; Matsumoto K; Kataoka Y; Arima Y; Inoue T; Sorano S
    Mol Med Rep; 2012 Jul; 6(1):3-8. PubMed ID: 22484457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatologic manifestations of Hepatitis C Virus.
    Treppo E; Quartuccio L; Ragab G; DE Vita S
    Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
    Garini G; Allegri L; Vaglio A; Buzio C
    Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy.
    Rossi D; Sciascia S; Fenoglio R; Ferro M; Baldovino S; Kamgaing J; Ventrella F; Kalikatzaros I; Viziello L; Solfietti L; Barreca A; Roccatello D
    Minerva Med; 2021 Apr; 112(2):162-174. PubMed ID: 33198442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current therapeutic strategies for HCV-associated cryoglobulinemia].
    Iannuzzella F; Garini G
    Reumatismo; 2008; 60(3):163-73. PubMed ID: 18854876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cryoglobulins and cryoglobulinemic vasculitis].
    Suszek D; Majdan M
    Wiad Lek; 2018; 71(1 pt 1):59-63. PubMed ID: 29558353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements.
    Dammacco F; Lauletta G; Vacca A
    Clin Exp Med; 2023 Jun; 23(2):255-272. PubMed ID: 35348938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the Cryoglobulinemias.
    Fuentes A; Mardones C; Burgos PI
    Curr Rheumatol Rep; 2019 Nov; 21(11):60. PubMed ID: 31741077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryoglobulinemic vasculitis.
    Ferri C; Mascia MT
    Curr Opin Rheumatol; 2006 Jan; 18(1):54-63. PubMed ID: 16344620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Delluc A; Piette JC; Cacoub P
    Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus-related cryoglobulinemic vasculitis.
    Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
    Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
    Giuggioli D; Manfredi A; Colaci M; Manzini CU; Antonelli A; Ferri C
    Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.
    Dammacco F; Lauletta G; Russi S; Leone P; Tucci M; Manno C; Monaco S; Ferrari S; Vacca A; Racanelli V
    Clin Exp Med; 2019 Feb; 19(1):1-21. PubMed ID: 30430284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.
    Roccatello D; Sciascia S; Rossi D; Solfietti L; Fenoglio R; Menegatti E; Baldovino S
    Oncotarget; 2017 Jun; 8(25):41764-41777. PubMed ID: 28454112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study.
    Chang ML; Cheng JS; Chuang YH; Pao LH; Wu TS; Chen SC; Chang MY; Chien RN
    Front Immunol; 2022; 13():823160. PubMed ID: 35371039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cryoglobulinemic vasculitis].
    Specker C; Passens D; Schlaak J
    Z Rheumatol; 2022 May; 81(4):300-304. PubMed ID: 35258723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term remission with rituximab in a patient with severe hepatitis C virus-induced mixed cryoglobulinemia.
    Fortea-Ormaechea JI; Lozano-Maya M; Adán-Merino L; Barrio-Antoranz J; Martín-Chavarri S; Corchete-Prats E; Martínez-Acebes E; Aldeguer-Martínez M
    Rev Esp Enferm Dig; 2013 Sep; 105(8):490-3. PubMed ID: 24274448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis C Virus-Induced Cryoglobulinemic Vasculitis].
    Minami Y; Kudo M
    Brain Nerve; 2018 Feb; 70(2):133-137. PubMed ID: 29433114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed cryoglobulinemia.
    Ferri C
    Orphanet J Rare Dis; 2008 Sep; 3():25. PubMed ID: 18796155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.